| Literature DB >> 35996161 |
Urs Granacher1, Hassane Zouhal2,3, Fatma Rhibi4,5, Abderraouf Ben Abderrahman6, Jacques Prioux5, Cain C T Clark7, Benoît Bideau5, Sophia Besbes8, Anthony C Hackney9.
Abstract
This study aimed to examine the effects of two high-intensity interval training programs (HIIT) on maximal aerobic velocity (MAV), hematological variations and muscle damage markers in young healthy adults. Twenty-nine male physical education students, aged 20.3 ± 3.3 years, volunteered to participate in this study, and were randomly assigned to a control group (CG, n = 9) or two intervention groups (group 1 or 2). Intervention group 1 (n = 10) exercised at 100% of their MAV (EG100) while group 2 (n = 10) exercised at 110% MAV (EG110). Before and after the eight week training program, blood samples were drawn at rest, before, and after an intermittent exercise. Aspartate aminotransferase (ASAT), alanine aminotransferase (ALAT), C reactive protein (CRP), creatine kinase (CK) concentrations and hematological parameters (white blood cells [WBC], monocytes [MO], lymphocytes [LY], neutrophil [NE]) and lactate dehydrogenase (LDH) were measured. Post-hoc tests showed that MAV was significantly higher in EG110 compared to EG100 after HIIT (p < 0.01, ηp2 = 0.05), whilst ALAT, ASAT, and CPR were significantly lower (p < 0.01; 0.02 < ηp2 < 0.11) in EG110 compared to EG100. Moreover, post-hoc tests indicated that LY decreased significantly (p < 0.001, ηp2 = 0.21) only for EG110. Furthermore, there were significant positive correlations for both EG100 and EG110 between MAV and ALAT (r = 0.66, p = 0.044 and r = 0.64, p = 0.041 respectively), CK (r = 0.67, p = 0.031 and r = 0.86, p = 0.030, respectively), LDH (r = 0.74, p = 0.014, and r = 0.071, p = 0.021, respectively). In addition, there was a significant positive correlation for both, EG100 and EG110 between MAV and LY (r = 0.79, p < 0.01; r = 0.72, p < 0.05, respectively). Concerning the relationship between MAV and NE, there was a significant positive correlation (r = 0.66; p < 0.05) only for EG110. Findings from this study revealed that HIIT at 110% MAV was more efficient to improve MAV and reduce muscle damage. In addition, we observed significant associations between performance improvements (MAV) and markers of muscle damage.Entities:
Keywords: Hematological parameters; Immunological parameters; Intermittent exercise; Performances
Year: 2022 PMID: 35996161 PMCID: PMC9396849 DOI: 10.1186/s13102-022-00550-x
Source DB: PubMed Journal: BMC Sports Sci Med Rehabil ISSN: 2052-1847
Mean (± SD) values for age and anthropometric characteristics for all groups
| Variables | Group | Pre | Post | |||
|---|---|---|---|---|---|---|
| main effect of group | main effect of time | group x time interaction | ||||
| Body mass (kg) | EG100 | 72.7 ± 8.1 | 72.2 ± 7.7 | 0.532 (0.12) | 0.910 (0.01) | 0.233 (0.13) |
| EG110 | 72.9 ± 6.2 | 72.4 ± 6.1 | ||||
| CG | 72.5 ± 4.2 | 72.3 ± 3.7 | ||||
| Body height (cm) | EG100 | 178.8 ± 5.4 | 179.0 ± 5.3 | 0.786 (0.03) | 0.340 (0.17) | 0.345 (0.08) |
| EG110 | 180.9 ± 6.8 | 181.0 ± 6.8 | ||||
| CG | 180.1 ± 6.2 | 179.9 ± 5.7 | ||||
| BMI (kg.m−2) | EG100 | 22.7 ± 1.3 | 22.5 ± 1.2 | 0.368 (0.09) | 0.162 (0.12) | 0.197 (0.11) |
| EG110 | 22.3 ± 1.4 | 22.1 ± 1.3 | ||||
| CG | 22.4 ± 1.0 | 22.3 ± 0.9 | ||||
| BF (%) | EG100 | 11.6 ± 1.1 | 11.5 ± 1.2 | 0.791 (0.02) | 0.103 (0.16) | 0.174 (0.13) |
| EG110 | 11.4 ± 1.5 | 11.3 ± 1.4 | ||||
| CG | 11.8 ± 1.4 | 11.9 ± 1.4 | ||||
| MAV (km.h−1) | EG100 | 15.82 ± 1.61 | 16.74 ± 1.48 a | 0.591 (0.05) | < 0.001 (0.71) | < 0.001 (0.61) |
| EG110 | 16.14 ± 2.10 | 17.58 ± 2.16 ac | ||||
| CG | 16.09 ± 1.95 | 16.13 ± 1.83 | ||||
Data are mean values (± SD), BM, body mass; BMI, body mass index; BF, Body fat; EG100, trained group with 100% MAV (n = 10); MAV, Maximal aerobic velocity; EG110, trained group with 110% MAV (n = 10); CG, control group (n = 9); HIIT, high intensity interval training program; pre-test, before HIIT; post-test, after HIIT
a: significant difference between before and after HIIT
c: significant difference between EG100 and EG110
Fig. 1Study design for both experimental groups and control groups and experimental design for blood sampling
Exercise characteristics of the two intervention groups
| Week | Week 1 | Week 2 | Week 3 | Week 4 | Week 5 | Week 6 | Week 7 | Week 8 |
|---|---|---|---|---|---|---|---|---|
| Set × (repetition) | 2 × (8 × 30sIE) | 2 × (9 × 30sIE) | 2 × (10 × 30sIE) | 2 × (11 × 30sIE) | 2 × (10 × 30sIE) | 2 × (12 × 30sIE) | 2 × (12 × 30sIE) | 2 × (11 × 30sIE) |
| Intensity | 100% MAV/50% | 100% MAV/50% | 100% MAV/50% | 100% MAV/50% | 100% MAV/50% | 100% MAV/50% | 100% MAV/50% | 100% MAV/50% |
| TL | 1200 ATU | 1350 ATU | 1500 ATU | 1650 ATU | 1500 ATU | 1800 ATU | 1800 ATU | 1650 ATU |
| Set × (repetition) | 2 × (8 × 30sIE) | 2 × (9 × 30sIE) | 2 × (10 × 30sIE) | 2 × (11 × 30sIE) | 2 × (10 × 30sIE) | 2 × (12 × 30sIE) | 2 × (12 × 30sIE) | 2 × (11 × 30sIE) |
| Intensity | 110% MAV/50% | 110% MAV/50% | 110% MAV/50% | 110% MAV/50% | 110% MAV/50% | 110% MAV/50% | 110% MAV/50% | 110% MAV/50% |
| TL | 1280 ATU | 1440 ATU | 1600 ATU | 1760 ATU | 1600 ATU | 1920 ATU | 1920 ATU | 1760 ATU |
MAV, Maximal aerobic velocity; EG100, 100% MAV training group (n = 10); EG110, 110% MAV training group (n = 10); TL, Training load; ATU, Arbitrary training units; Example: [2 × (8 × 30 s / 30 s) 100/50% MAV]; It means that the participant had to run two series with eight repetitions each 30 s composed of 30 s running at 100% of MAV and 30 s active recovery at 50% of MAV. The participant recovers passively 5 min between each series. Each session was repeated 3 times per week
Mean (± SD) values for muscle-damage markers measured during 30 s intermittent exercise before and after HIIT
| Variables | Group | Pre | Post | |||
|---|---|---|---|---|---|---|
| Main effect of group | Main effect of time | Group × time interaction | ||||
| ALAT (UI/L) | EG100 | 20.4 ± 3.4 | 18.6 ± 3.4 a | 0.379 (0.08) | < 0.001 (0.44) | < 0.001 (0.57) |
| EG110 | 20.0 ± 3.4 | 17.0 ± 3.5 ac | ||||
| CG | 20.4 ± 3.6 | 20.7 ± 3.5 | ||||
| ASAT (UI/L) | EG100 | 21.1 ± 4.4 | 19.2 ± 3.5 a | 0.851 (0.02) | < 0.001 (0.56) | 0.006 (0.29) |
| EG110 | 20.3 ± 4.8 | 17.4 ± 3.7 ac | ||||
| CG | 20.2 ± 3.7 | 19.6 ± 2.9 | ||||
| CRP (mg/L) | EG100 | 4.0 ± 0.8 | 3.5 ± 0.5 a | 0.395 (0.08) | < 0.001 (0.41) | 0.019 (0.17) |
| EG110 | 3.5 ± 1.1 | 3.2 ± 0.8 a | ||||
| CG | 3.8 ± 0.7 | 3.7 ± 0.7 | ||||
| CK (Ul/L) | EG100 | 201.9 ± 65.7 | 179.5 ± 58.6 | 0.831 (0.02) | < 0.001 (0.48) | 0.008 (0.28) |
| EG110 | 197.0 ± 43.7 | 166.0 ± 40.8 a | ||||
| CG | 205.3 ± 68.7 | 192.9 ± 51.8 | ||||
| LDH (Ul/L) | EG100 | 199.7 ± 26.0 | 173.5 ± 28.3 a | 0.843 (0.07) | 0.004 (0.29) | 0.012 (0.37) |
| EG110 | 208.8 ± 67.8 | 167.0 ± 47.8 ac | ||||
| CG | 194.8 ± 24.5 | 192.8 ± 18.6 | ||||
EG100, trained group with 100% MAV (n = 10); EG110, trained group with 110% MAV (n = 10); CG, control groups without HIIT (n = 9); HIIT, High intensity interval training program; pre-test, before HIIT; post-test, after HIIT; ALAT, alanine aminotransferase; ASAT, aspartate aminotransferase; CK, creatine kinase; CRP, C-reactive protein, LDH, lactate dehydrogenase
a: significant difference between before and after HIIT
c: significant difference between EG100 and EG110
Mean (± SD) values for hematological parameters measured during 30 s intermittent exercise pre, post HIIT
| Variables | Group | Pre | Post | |||
|---|---|---|---|---|---|---|
| Main effect of group | Main effect of time | Group x time interaction | ||||
| WBC (103 /μl) | EG100 | 7.1 ± 1.1 | 6.7 ± 1.1 a | 0.646 (0.04) | < 0.001 (0.43) | 0.013 (0.26) |
| EG110 | 7.1 ± 1.1 | 6.6 ± 1.2 a | ||||
| CG | 7.3 ± 0.8 | 7.3 ± 0.8 | ||||
| NE (103 /μl) | EG100 | 4.0 ± 0.6 | 3.7 ± 0.5 a | 0.632 (0.04) | < 0.001 (0.41) | 0.031 (0.22) |
| EG110 | 4.1 ± 0.9 | 3.7 ± 0.8 a | ||||
| CG | 3.9 ± 0.6 | 4.0 ± 0.6 | ||||
| LY (103 /μl) | EG100 | 2.6 ± 0.8 | 2.5 ± 0.8 | 0.919 (0.02) | < 0.001 (0.33) | 0.005 (0.19) |
| EG110 | 2.7 ± 0.8 | 2.1 ± 0.2 ac | ||||
| CG | 2.5 ± 0.6 | 2.5 ± 0.7 | ||||
| MO (103 /μl) | EG100 | 0.6 ± 0.2 | 0.5 ± 0.1 | 0.886 (0.02) | 0.051 (0.10) | 0.351 (0.08) |
| EG110 | 0.6 ± 0.1 | 0.5 ± 0.1 | ||||
| CG | 0.6 ± 0.1 | 0.5 ± 0.1 | ||||
EG100, trained group with 100% MAV (n = 10); EG110, trained group with 110% MAV (n = 10); CG, control groups without HIIT (n = 9); HIIT, High intensity interval training program. pre-test, before HIIT; post-test, after HIIT; WBC, white blood cells; NE, neutrophils; LY, lymphocytes; MO, monocytes
a: significant difference between before and after HIIT
c: significant difference between EG100 and EG110
Correlations between percentage changes of maximal aerobic velocity (MAV) and deltas in hematological and muscle-damage markers
| % Change | Pearson's r ( | |||
|---|---|---|---|---|
| EG100 | EG110 | EG100 | EG110 | |
| MAV | + 5.9 | + 8.9% | ||
| ALAT (UI/L) | − 9.0% | − 15.2% | 0.66 (0.0438)* | 0.64 (0.041)* |
| ASAT (UI/L) | − 8.3% | − 12.4% | 0.54 (0.107) | 0.39 (0.265) |
| CRP (mg/L) | − 11.0% | − 4.8% | 0.40 (0.252) | 0.07 (0.487) |
| CK (Ul/L) | − 10.7% | − 14.6% | 0.67 (0.031)* | 068 (0.030)* |
| LDH (Ul/L) | − 13.4% | − 18.5% | 0.74 (0.014)* | 0.71 (0.021)* |
| WBC (103 /μl) | − 5.7% | − 7.5% | 0.58 (0.078) | 0.55 (0.099) |
| NE (103 /μl) | − 7.1% | − 8.2% | 0.61 (0.061) | 0.66 (0.037)* |
| LY (103 /μl) | − 5.1% | − 19.2% | 0.79 (0.006)** | 0.72 (0.018)** |
| MO (103 /μl) | − 12.6% | − 10.4% | 0.42 (0.226) | 0.22 (0.541) |
EG100, trained group with 100% MAV (n = 10); EG110, trained group with 110% MAV (n = 10); MAV, maximal aerobic velocity; ALAT, alanine aminotransferase; ASAT, aspartate aminotransferase; CK, creatine kinase; CRP, C-reactive protein; LDH, lactate dehydrogenase.WBC, white blood cells; NE, neutrophils; LY, lymphocytes; MO, monocytes. *Significant correlation, *p<0.05, **p<0.01